Search

Home > News & Events > Current News

Current News

Current SATVI news

15 November 2018 LATEST RESEARCH: Commentary WHO Preferred Product Preferences for TB Vaccines
Thursday, November 15, 2018 - 11:30

SATVI Director Professor Mark Hatherill has co-authored a commentary titled "WHO preferred product characteristics for new vaccines against tuberculosis" appearing in The Lancet journal.

13 November 2018 RESEARCH Can we predict tuberculosis cure? What tools are available?
Tuesday, November 13, 2018 - 12:45

Associate Professor Tom Scriba has co authored a paper titled "Can we predict tuberculosis cure? What tools are available?" appearing in the European Respiratory Journal of the European Respiratory Society.

LIVE PRESS CONFERENCE: Union World Conference on Lung Health : M72 Vaccine study primary results presented
Sunday, October 28, 2018 - 09:30

Watch the press conference during which the primary results from the M72/AS01E candidate vaccine were announced during the Union World Conference on Lung Health. Professor Mark Hatherill, SATVI Director spoke on behalf of SATVI.

23 October 2018 SATVI at the Union Conference on Lung Health
Tuesday, October 23, 2018 - 12:00

View the full list of SATVI speakers at the The Union World Conference on Lung Health held from 24 to 27 October 2018.

25 September 2018 Research Published: Candidate tuberculosis (TB) vaccine can prevent active pulmonary TB in HIV-negative adults in phase II study
Tuesday, September 25, 2018 - 17:45

The New England Journal of Medicine has just published the primary results of an ongoing phase IIb clinical trial testing the candidate tuberculosis vaccine M72/AS01E which demonstrates that the M72/AS01E vaccine significantly reduced the incidence of pulmonary tuberculosis disease in HIV-negative adults who were already infected with latent TB at the time of vaccination.

7 September 2018 Latest Research: PD-1 Expression on Mycobacterium tuberculosis-Specific CD4 T Cells Is Associated With Bacterial Load in Human Tuberculosis
Friday, September 7, 2018 - 16:00

SATVI Researcher Marwou de Kock has co-authored a research article titled: "PD-1 Expression on Mycobacterium tuberculosis-Specific CD4 T Cells Is Associated With Bacterial Load in Human Tuberculosis" appearing in the Frontiers in Immunology journal.

Latest Research: Differential DNA methylation of potassium channel KCa3.1 and immune signalling pathways is associated with infant immune responses following BCG vaccination
Wednesday, September 5, 2018 - 11:45

SATVI Associate Professor Tom Scriba has co-authored a research paper titled "Differential DNA methylation of potassium channel KCa3.1 and immune signalling pathways is associated with infant immune responses following BCG vaccination" appearing in the Scientific Reports journal.

Coming Event: Kick TB Poster and Writing Exhibit
Monday, August 27, 2018 - 10:30

SATVI and the Western Department of Education are pleased to announce the hosting of the Kick TB Poster Art and Writing Exhibit on Monday 3 September 2018.

22 August 2018 Research Published: Infectious Diseases: Natural killers associated with latent Tuberculosis
Wednesday, August 22, 2018 - 22:00

SATVI authors Associate Professor Tom Scriba, Drs. Elisa Nemes, Adam Penn-Nicholson, Virginie Rozot and Fatoumatta Darboe have co-authored an article titled: "A multi-cohort study of the immune factors associated with M. tuberculosis infection outcomes" appearing in the Nature Journal.

20 August 2018 Research Published: Integrating Non-human Primate, Human, and Mathematical Studies to Determine the Influence of BCG Timing on H56 Vaccine Outcomes
Tuesday, August 21, 2018 - 11:15

Associate Professor Tom Scriba has co-authored a research paper titled: "Integrating Non-human Primate, Human, and Mathematical Studies to Determine the Influence of BCG Timing on H56 Vaccine Outcomes" appearing in the Frontiers journal.

17 August 2018 Research: Prospects for a vaccine to prevent HIV related Tuberculosis
Monday, August 20, 2018 - 15:45

SATVI Authors dr Elisa Nemes, Professor Mark Hatherill and Associate Professor Tom Scriba have published a paper titled: "Prospects for a vaccine to prevent HIV related Tuberculosis" appearing in the Current opinions in HIV/AIDS journal.

Celebrating the legacy of Nelson Mandela
Thursday, July 19, 2018 - 12:45

For this year’s Mandela Day the South African Tuberculosis Vaccine Initiative (SATVI) has announced its support for community based soup kitchens in the Cape Winelands District.

Pages